Stay updated on PD-1 and Cell Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 and Cell Therapy in NSCLC Clinical Trial page.

Latest updates to the PD-1 and Cell Therapy in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing Revision: v3.6.3. This indicates a page version update rather than changes to the study information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s revision identifier was updated from v3.6.2 to v3.6.3, indicating a small build/patch of the site. This update does not alter study information or visible page functionality.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, signaling a minor update to the page rendering or content.SummaryDifference0.1%

- Check51 days agoChange DetectedRecruitment status is updated to indicate no more participants are being sought. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was adjusted, with the revision label updated to v3.6.0.SummaryDifference0.5%

- Check58 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a new version of the page content. This appears to be a minor update to metadata or formatting rather than substantive changes to the study details or user-facing functionality.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the study record. This appears to be a metadata revision rather than a substantive change to the trial details.SummaryDifference0.1%

Stay in the know with updates to PD-1 and Cell Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and Cell Therapy in NSCLC Clinical Trial page.